Clinical Trials Directory

Trials / Completed

CompletedNCT05471518

Sex Hormone and Vascular Function in Women With CKD

Status
Completed
Phase
Study type
Observational
Enrollment
51 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers

Summary

The risk of cardiovascular disease (CVD) is significantly elevated in patients with chronic kidney disease (CKD). Notably, women with CKD commonly experience menstrual disturbances induced by CKD, which may contribute to impaired vascular function and elevated CVD risk. However, most of the literature in the field of nephrology focuses on male patients, and studies on women's vascular health are limited. Moreover, endogenous sex hormones, particularly estradiol, are well-documented to be cardioprotective in women without CKD; however, the role of sex hormones on vascular function in women with CKD remains unclear. The goals of the proposed project are: 1) to evaluate vasuclar function in pre- and post-menopausal women with CKD vs. age-matched healthy women; 2) to evaluate sex hormone concentrations and determine whether they associate with vascular function in the proposed cohort; and 3) to gain mechanistic insight on the association between sex hormones and vascular dysfunction in the proposed cohort.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2021-07-01
Primary completion
2024-11-30
Completion
2024-11-30
First posted
2022-07-22
Last updated
2025-09-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05471518. Inclusion in this directory is not an endorsement.

Sex Hormone and Vascular Function in Women With CKD (NCT05471518) · Clinical Trials Directory